Serum Institute Gets Nod To Resume Oxford COVID-19 Vaccine Trial In India

Drugs Controller General of India Dr VG Somani gave permission to Serum Institute of India to resume clinical trial of the Oxford COVID-19 vaccine candidate in the country.

from NDTV News - Latest https://ift.tt/2Rxkbqa